{"id":111611,"date":"2022-09-12T14:10:00","date_gmt":"2022-09-12T14:10:00","guid":{"rendered":"https:\/\/omni48.com\/news\/ventyx-inmed-top-healthcare-gainers-akari-apexigen-lead-losers-pack"},"modified":"2022-09-12T14:10:00","modified_gmt":"2022-09-12T14:10:00","slug":"ventyx-inmed-top-healthcare-gainers-akari-apexigen-lead-losers-pack","status":"publish","type":"post","link":"https:\/\/omni48.com\/news\/ventyx-inmed-top-healthcare-gainers-akari-apexigen-lead-losers-pack","title":{"rendered":"Ventyx, InMed top healthcare gainers; Akari, Apexigen lead losers&#8217; pack"},"content":{"rendered":"","protected":false},"excerpt":{"rendered":"<p>Gainers: Ventyx Biosciences (VTYX) +66%. InMed Pharmaceuticals (INM) +28%. Regulus Therapeutics (RGLS)&#8230;<\/p>\n","protected":false},"author":0,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[1],"tags":[27,44,29,399],"class_list":["post-111611","post","type-post","status-publish","format-standard","hentry","category-news","tag-economy","tag-industry","tag-markets","tag-medical-biotech"],"acf":[],"_links":{"self":[{"href":"https:\/\/omni48.com\/api\/wp\/v2\/posts\/111611","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/omni48.com\/api\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/omni48.com\/api\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/omni48.com\/api\/wp\/v2\/comments?post=111611"}],"version-history":[{"count":0,"href":"https:\/\/omni48.com\/api\/wp\/v2\/posts\/111611\/revisions"}],"wp:attachment":[{"href":"https:\/\/omni48.com\/api\/wp\/v2\/media?parent=111611"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/omni48.com\/api\/wp\/v2\/categories?post=111611"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/omni48.com\/api\/wp\/v2\/tags?post=111611"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}